Post Hoc Analysis of a Randomized, Double-Blind, Prospective Trial Evaluating a CXCR1/2 Inhibitor in New-Onset Type 1 Diabetes: Endo-Metabolic Features at Baseline Identify a Subgroup of Responders.
FRONTIERS IN ENDOCRINOLOGY(2023)
关键词
IL-8,CXCR1,CXCR2,type 1 diabetes mellitus,trial,post hoc analyses
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要